Arrowhead Research | ARWR - Market Capitalization

Stock Price
76.67
Daily Change
-3.02 -3.79%
Monthly
12.78%
Yearly
388.03%
Q2 Forecast
75.13

Arrowhead Research reported $9.71B in Market Capitalization this May of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Agios Pharmaceuticals USD 2.01B 423M Mar/2026
Alnylam Pharmaceuticals USD 44.15B 8.39B Mar/2026
Anika Therapeutics USD 139M 3M Dec/2025
Arrowhead Research USD 9.7B 920M May/2026
Heron Therapeutics USD 238M 7M Dec/2025
Incyte USD 21.73B 3B May/2026
Ionis Pharmaceuticals USD 12.46B 356M Mar/2026
Ligand Pharmaceuticals USD 3.72B 257M May/2026
Merck USD 297.1B 35.84B Mar/2026
Moderna USD 20.15B 8.53B Mar/2026
Nektar Therapeutics USD 15.62B 14.76B May/2026
Novartis USD 232.75B 75B May/2026
Sarepta Therapeutics USD 2.16B 123M May/2026
TG Therapeutics USD 6.48B 1.18B May/2026
Ultragenyx Pharmaceutical USD 2.06B 1000K May/2026
Vertex Pharmaceuticals USD 113.58B 1000K May/2026
Xencor USD 795M 98M May/2026